Susquehanna Fundamental Investments, LLC Biocryst Pharmaceuticals Inc Transaction History
Susquehanna Fundamental Investments, LLC
- $4.33 Trillion
- Q2 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 30,176 shares of BCRX stock, worth $229,941. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,176
Previous 64,365
53.12%
Holding current value
$229,941
Previous $327 Million
42.97%
% of portfolio
0.0%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding BCRX
# of Institutions
280Shares Held
171MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$155 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$152 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$90.4 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$69.2 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$67.4 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.42B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...